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Case report Undifferentiated spondyloarthritis following 
allogeneic stem cell transplantation
Vijay R Karia*, Raquel Cuchacovich and Luis R Espinoza
Abstract
Background: Stem cell transplant has been utilized in the treatment of malignancies and rheumatic disease. 
Rheumatic disease may be transferred from the donor with active disease or may be developed in a recipient de novo 
as a late complication of SCT.
Case Presentation: We here report the rare case of a 26-year old male patient, who has been diagnosed with 
undifferentiated spondyloarthropathy after unique circumstance. The patient suffered from intermittent inflammatory 
back pain and peripheral joint swelling for several years and did not find relief through multiple emergency room visits 
at different medical facilities. After a thorough history and physical exam, it was noted that our patient had developed 
signs of axial disease along with dactylitis and overall that he had been insidiously developing an undifferentiated 
spondyloarthopathy after allogeneic stem cell transplantation.
Conclusion: Our observation supports the hypothesis that de novo rheumatic disease can develop after stem cell 
transplant for a variety of reasons. Thus, larger studies and awareness of this association are needed to delineate the 
exact underlying mechanism(s).
Background
Both autologous and allogeneic stem cell transplantation
(SCT) have become standard therapeutic modalities for
lymphoid proliferative and certain autoimmune/rheu-
matic disorders [1,2]. With modified protocols to ensure
less profound depletion of T cells, better control of sys-
temic disease prior to transplantation, antiviral prophy-
laxis after transplantation, and slower tapering of
corticosteroids both morbidity and mortality complica-
tions following SCT have significantly declined in recent
years [3]. The development, however, of de novo rheu-
matic disorders is being increasingly recognized follow-
ing either autologous or allogeneic SCT procedures [4-6].
The purpose of this report is to describe a patient in
whom undifferentiated spondyloarthritis developed fol-
lowing allogeneic SCT.
Some rheumatic diseases appear to be directly related
to SCT itself, while others may be associated to the ther-
apy used (Additional File 1). Wagener et al. first brought
into attention the development of musculoskeletal com-
plaints following allogeneic but not autologous bone mar-
row transplantation [4]. Oligoarthritis occurring in 18/33
and avascular bone necrosis in 8/33 patients were noted.
Since then several case reports or small series have
appeared describing the development of a variety of rheu-
matic disorders including rheumatoid arthritis, HLA-B27
related spondyloarthritis, psoriatic arthritis, vasculitides
syndromes including ANCA-associated small vessel vas-
culitis, eosinophilic fasciitis, ANA positivity, and
antiphospholipid syndrome [7-12]. Gouty and acute
inflammatory arthritis following the use of recombinant
granulocyte colony-stimulating factor therapy has also
been described in SCT patients [13,14]. Immune-medi-
ated thyroid disease and cytopenias including Evans syn-
drome, hemolytic anemia, and thrombotic
thrombocytopenic purpura (TTP)-like syndromes con-
stitute another group of disorders seen in SCT [12,15].
A literature search along with consultation of leading
hematologists was performed to find the current level of
science in stem cell transplantation. Through our work,
we found that a few other authors have noticed the phe-
nomenon of autoimmune disease transmission after stem
cell transplantation.
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Our patient exhibits clinical manifestations associated
with undifferentiated spondyloarthropathy [16]. HLA-
B27 was not detected, but the presence of oligoarthritis,
unilateral sacroiliitis, dactylitis, and enthesitis and a posi-
tive family history of psoriasis fulfill classification criteria
for spondyloarthritis-most likely undifferentiated spon-
dyloarthritis.
Case Presentation
A 26-year-old white man diagnosed with acute pre-B
lymphocytic leukemia (ALL) at age 10 refractory to che-
motherapy for which he underwent a haplo-identical
allogeneic stem cell transplantation (SCT) from his father
who did not have any rheumatic and/or dermatologic
inflammatory diseases including psoriasis. Except for a
febrile and convulsive episode that lasted only a few days
with a very good response to a short course of oral pred-
nisone, he remained well until about 10 years later when
he began to exhibit lower back pain and stiffness. On
Christmas day 2003, he woke up with a painful, stiff and
swollen right ankle which made walking very difficult.
From December 2003 onwards the patient complained of
right ankle pain, swelling and stiffness with difficulty in
walking and only partial and transient clinical response to
indomethacin, colchicine and allopurinol therapy. In Jan-
uary 2008, he presented to a local emergency room with a
painful, stiff, and swollen right elbow for which he
received a short course of oral prednisone. Over the sub-
sequent 4 months, he continued to have right elbow and
ankle pain and swelling accompanied by difficulty using
his arm and walking. In May 2008, he was admitted to
our University Hospital for left elbow and hand swelling
and pain. On physical examination, blood pressure was
131/73, pulse 81, height 5'8", weight 215, BMI 31.6. He
was in distress and pertinent findings revealed the pres-
ence of mild flaking and dryness of earlobes overlying
skin, swelling, redness and tenderness of the second digit
distal interphalangeal joint of left hand, swelling, tender-
ness, and decreased range of motion of right ankle, sau-
sage digit deformity of the middle digit of the left foot,
and enthesitis of the right Achilles tendon (Figures 1, 2,
3). In addition, both sacroiliac joints were tender to pal-
pation and a Schober test was positive. Past history:
Hypertension, bilateral cataracts, and metabolic syn-
drome. Family history: Paternal grandfather had psoriasis
and also suffered from stiff hands. Maternal grandmother
had a history of rheumatoid arthritis for over 30 years.
Laboratory findings: ESR: 56 mm/h (n < 20), CRP: 17.02
mg/dL (n < 0.80). Rheumatoid factor, CCP antibodies,
ANA, and HLA-B27 were negative and/or normal. Hands
and feet radiographs did not show erosions. Sacroiliac
joints x-ray showed unilateral sacroiliitis (Figure 4). Fol-
low-up: patient is improved on symptomatic NSAID
therapy.
Conclusion
We present an interesting patient who has undergone
stem cell transplantation for the treatment of pre-B lym-
phocytic leukemia and was in remission. However, his
development of a de novo rheumatic disease was recog-
nized by us and the incidence is increasing according to
recent medical literature. We reviewed current theories
regarding the reasons behind autoimmune disease trans-
fer between donor and recipient and postulate that our
patient fits into the current science.
One could consider the development of de novo auto-
immune disease as a possible side effect of stem cell
transplantation. These serious secondary effects of stem
cell transplantation must be taken into account as tertiary
centers continue using SCT as a modality for the treat-
ment of rheumatic and hematologic disease.
The exact pathophysiology of both rheumatic and
immune-mediated disorders is not fully understood. It is
Figure 1 Left index finger demonstrating DIP involvement.

Figure 2 Left foot exhibiting diffuse swelling with prominent DIP 
involvement.
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quite likely, however, that multiple factors including
genetic predisposition, environmental factors such as
CMV infection, drug exposure, abnormal reconstitution
of the immune system, and direct transfer of pathogenic
hematopoietic stem cells from the donor that could gen-
erate autoreactive clones in allogeneic transplants-possi-
bly the case in our patient, might participate.
Inflammatory cytokines, chemokines and adhesion mole-
cules, particularly interleukin-8 and drugs used during
SCT such as cyclosporine A or tacrolimus may also play
an important role in inducing vascular endothelial dam-
age leading to TTP-like syndromes.
Our patient revealed a clinical picture consistent with
undifferentiated spondyloarthritis which developed fol-
lowing allogeneic SCT. The exact incidence as well as the
pathophysiology of this complication is unknown, but
larger studies are needed to develop preventive measures.
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